ID IB3-1 AC CVCL_0338 SY IB3 DR BTO; BTO_0004445 DR CLO; CLO_0004329 DR EFO; EFO_0001194 DR MCCL; MCC:0000234 DR ATCC; CRL-2777 DR ATCC; JHU-52 DR BCRJ; 0114 DR ChEMBL-Cells; CHEMBL4295410 DR ChEMBL-Targets; CHEMBL4296439 DR PubChem_Cell_line; CVCL_0338 DR Wikidata; Q54897163 RX PubMed=1380129; RX PubMed=1849726; RX PubMed=7679117; RX PubMed=15463957; RX PubMed=16512671; RX PubMed=18441018; WW Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-527.html CC Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=15463957). CC Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (PubMed=15463957). CC Transformant: Ad12-SV40 hybrid virus. CC Omics: Proteomics; 2DE-MS. CC Discontinued: ATCC; CRL-2777; true. CC Discontinued: ATCC; JHU-52; true. ST Source(s): ATCC=CRL-2777 ST Amelogenin: X,Y ST CSF1PO: 10,11 ST D13S317: 8,12,13 ST D16S539: 9,11 ST D5S818: 11,12,13 ST D7S820: 11,12 ST TH01: 8,9.3 ST TPOX: 8,9 ST vWA: 15,18 DI NCIt; C2975; Cystic fibrosis DI ORDO; Orphanet_586; Cystic fibrosis OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 7Y CA Transformed cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 23 CH CVCL_4462 ! IB3-1/C38 CH CVCL_4461 ! IB3-1/S9 // RX PubMed=7679117; DOI=10.1016/S0021-9258(18)53762-5; RA Flotte, Terence R. RA Afione, Sandra A. RA Solow, Rikki RA Drumm, Mitchell L. RA Markakis, Diane RA Guggino, William B. RA Zeitlin, Pamela L. RA Carter, Barrie J. RT "Expression of the cystic fibrosis transmembrane conductance regulator RT from a novel adeno-associated virus promoter."; RL J. Biol. Chem. 268:3781-3790(1993). // RX PubMed=16512671; DOI=10.1021/pr050319o; RA Singh, Om V. RA Vij, Neeraj RA Mogayzel, Peter Joseph Jr. RA Jozwik, Catherine Edith RA Pollard, Harvey B. RA Zeitlin, Pamela L. RT "Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis RT bronchial epithelial cells."; RL J. Proteome Res. 5:562-571(2006). // RX PubMed=15463957; DOI=10.1016/j.jcf.2004.05.040; RA Gruenert, Dieter C. RA Willems, Marjolaine RA Cassiman, Jean-Jacques RA Frizzell, Raymond A. RT "Established cell lines used in cystic fibrosis research."; RL J. Cyst. Fibros. 3:191-196(2004). // RX PubMed=1380129; DOI=10.1038/358581a0; RA Egan, Marie RA Flotte, Terence R. RA Afione, Sandra A. RA Solow, Rikki RA Zeitlin, Pamela L. RA Carter, Barrie J. RA Guggino, William B. RT "Defective regulation of outwardly rectifying Cl- channels by protein RT kinase A corrected by insertion of CFTR."; RL Nature 358:581-584(1992). // RX PubMed=1849726; DOI=10.1165/ajrcmb/4.4.313; RA Zeitlin, Pamela L. RA Lu, Luo RA Rhim, Johng Sik RA Cutting, Garry R. RA Stetten, Gail RA Kieffer, K.A. RA Craig, Robert RA Guggino, William B. RT "A cystic fibrosis bronchial epithelial cell line: immortalization by RT adeno-12-SV40 infection."; RL Am. J. Respir. Cell Mol. Biol. 4:313-319(1991). // RX PubMed=18441018; DOI=10.1194/jlr.M700388-JLR200; PMCID=PMC2444007; RA Andersson, Charlotte RA Al-Turkmani, M. Rabie RA Savaille, Juanito E. RA Alturkmani, Ragheed RA Katrangi, Waddah RA Cluette-Brown, Joanne E. RA Zaman, Munir M. RA Laposata, Michael RA Freedman, Steven D. RT "Cell culture models demonstrate that CFTR dysfunction leads to RT defective fatty acid composition and metabolism."; RL J. Lipid Res. 49:1692-1700(2008). //